AGC PHARMA CHEMICALS Trademark

Trademark Overview

On Tuesday, May 23, 2023, a trademark application was filed for AGC PHARMA CHEMICALS with the United States Patent and Trademark Office. The USPTO has given the AGC PHARMA CHEMICALS trademark a serial number of 98010169. The federal status of this trademark filing is REGISTERED as of Tuesday, January 7, 2025. This trademark is owned by AGC Inc.. The AGC PHARMA CHEMICALS trademark is filed in the Treatment & Processing of Materials Services category with the following description:

Custom manufacture of pharmaceuticals; custom manufacture of biopharmaceuticals; antibody purification for others; custom manufacture of synthetic preparation
agc pharma chemicals

General Information

Serial Number98010169
Word MarkAGC PHARMA CHEMICALS
Filing DateTuesday, May 23, 2023
Status700 - REGISTERED
Status DateTuesday, January 7, 2025
Registration Number7645549
Registration DateTuesday, January 7, 2025
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, April 23, 2024

Trademark Statements

Goods and ServicesCustom manufacture of pharmaceuticals; custom manufacture of biopharmaceuticals; antibody purification for others; custom manufacture of synthetic preparation
NOT AVAILABLE"PHARMA CHEMICALS"

Classification Information

International Class040 - Treatment of materials.
US Class Codes100, 103, 106
Class Status Code6 - Active
Class Status DateSunday, June 25, 2023
Primary Code040
First Use Anywhere DateSaturday, June 25, 2022
First Use In Commerce DateSaturday, June 25, 2022

Trademark Owner History

Party NameAGC Inc.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressTokyo 100-8405
JP
Party NameAGC Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressTokyo 100-8405
JP
Party NameAGC Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressTokyo 100-8405
JP

Trademark Events

Event DateEvent Description
Friday, May 26, 2023NEW APPLICATION ENTERED
Sunday, June 25, 2023NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Wednesday, February 14, 2024ASSIGNED TO EXAMINER
Thursday, February 22, 2024NON-FINAL ACTION WRITTEN
Thursday, February 22, 2024NON-FINAL ACTION E-MAILED
Thursday, February 22, 2024NOTIFICATION OF NON-FINAL ACTION E-MAILED
Wednesday, March 13, 2024EXAMINERS AMENDMENT -WRITTEN
Wednesday, March 13, 2024EXAMINERS AMENDMENT E-MAILED
Wednesday, March 13, 2024NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Wednesday, March 13, 2024EXAMINER'S AMENDMENT ENTERED
Wednesday, March 13, 2024APPROVED FOR PUB - PRINCIPAL REGISTER
Tuesday, April 23, 2024PUBLISHED FOR OPPOSITION
Tuesday, June 18, 2024NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Wednesday, April 3, 2024NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, April 23, 2024OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Thursday, October 3, 2024USE AMENDMENT FILED
Thursday, October 3, 2024TEAS STATEMENT OF USE RECEIVED
Saturday, December 14, 2024STATEMENT OF USE PROCESSING COMPLETE
Saturday, December 14, 2024CASE ASSIGNED TO INTENT TO USE PARALEGAL
Monday, December 16, 2024ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Monday, December 16, 2024NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Tuesday, January 7, 2025REGISTERED-PRINCIPAL REGISTER
Tuesday, January 7, 2025NOTICE OF REGISTRATION CONFIRMATION EMAILED

Related Keywords

chemicals pharma custom manufacture synthetic preparation others antibody pharmaceuticals biopharmaceuticals purification